Fat jabs like Ozempic and Mounjaro could be more effective than diabetes drugs at preventing the disease, a study suggests.
Researchers found that people taking the GLP-1 injections had a 31 per cent lower risk of developing type 2 diabetes than those taking metformin, the gold standard treatment for the condition.
They also had a 41 per cent lower risk of dying from any cause and were less likely to suffer a heart attack, stroke or heart failure.
Experts said the findings raise the prospect of the drugs – which are currently used to treat type 2 diabetes, as well as obesity –
To provide well-rounded coverage and a breadth of insight across various events, we rely on contributions from several staff writers, each bringing their own area of expertise to our publication.